Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

14.40
Delayed Data
As of Dec 05
 +0.25 / +1.77%
Today’s Change
7.86
Today|||52-Week Range
17.05
-2.96%
Year-to-Date

Today’s Trading

Previous close14.15
Today’s open14.40
Day’s range14.10 - 14.78
Volume588,075
Average volume (3 months)609,185
Market cap$1.0B
Dividend yield--
Data as of 12/05/2016

Growth & Valuation

Earnings growth (last year)+30.89%
Earnings growth (this year)+14.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+71.58%
P/E ratioNM
Price/Sales10.45
Price/Book2.64

Competitors

 Today’s
change
Today’s
% change
AMAGAMAG Pharmaceuticals...+1.17+3.54%
CHRSCoherus BioSciences ...+0.25+0.90%
CRSPCRISPR Therapeutics ...+1.91+10.04%
RTRXRetrophin Inc+0.57+2.85%
Data as of 12/05/2016

Financials

Next reporting dateFebruary 21, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$89.7M
Annual profit (last year)-$83.3M
Net profit margin-92.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Operating Officer
Matthew P. Ottmer
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs